Home » Roche Ends Deal With Ligand
Roche Ends Deal With Ligand
San Diego’s Ligand Pharmaceuticals said that Roche has terminated their collaboration and licensing agreement to develop a treatment for hepatitis C, according to a regulatory filing.
Xconomy
Xconomy
Upcoming Events
-
07May
-
14May
-
30May